Not applicableStudy completedNCT00828126What this trial is testingPET-CT in the Management of Patients With Stage III or IV Metastatic MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 38
Large-scale testing (Phase 3)Looking for participantsNCT07166406What this trial is testingTesting Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialWho this might be right forAdvanced Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8 NRG Oncology 226
Large-scale testing (Phase 3)Looking for participantsNCT06616584What this trial is testingAdding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)Who this might be right forRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8 SWOG Cancer Research Network 378
Testing effectiveness (Phase 2)Looking for participantsNCT05741164What this trial is testingPropranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+2 more Emory University 37
Testing effectiveness (Phase 2)Study completedNCT03201458What this trial is testingAtezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder CancerWho this might be right forGallbladder CarcinomaMetastatic CholangiocarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8+2 more National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)WithdrawnNCT03326258What this trial is testingGlembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Temporarily pausedNCT05050162What this trial is testingComparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck CancerWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hypopharyngeal Squamous Cell CarcinomaAdvanced Laryngeal Squamous Cell Carcinoma+7 more NRG Oncology 1,714
Early research (Phase 1)Active Not RecruitingNCT02142803What this trial is testingTORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid TumorsWho this might be right forAdult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Ended earlyNCT02917629What this trial is testingACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive TreatmentWho this might be right forOral Cavity NeoplasmOropharyngeal NeoplasmStage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7+11 more National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Looking for participantsNCT06173362What this trial is testingAbiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate CancerWho this might be right forAdvanced Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8 University of California, Davis 75
Testing effectiveness (Phase 2)Looking for participantsNCT05733000What this trial is testingCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsWho this might be right forAdvanced Biliary Tract CarcinomaAdvanced Colorectal CarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+30 more Northwestern University 94
Testing effectiveness (Phase 2)Study completedNCT01840007What this trial is testingPilot Study Evaluating the Efficacy and Safety of Metformin in MelanomaWho this might be right forMetastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC) Centre Hospitalier Universitaire de Nice 20
Testing effectiveness (Phase 2)Study completedNCT00654732What this trial is testingCombination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin LymphomaWho this might be right forClassic Hodgkin LymphomaLugano Classification Stage III Hodgkin Lymphoma AJCC v8Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8 M.D. Anderson Cancer Center 58
Early research (Phase 1)Study completedNCT01638533What this trial is testingRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)WithdrawnNCT03735589What this trial is testingSpecialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forStage II Fallopian Tube Cancer AJCC v8Stage II Ovarian Cancer AJCC v8Stage II Primary Peritoneal Cancer AJCC v8+31 more Roswell Park Cancer Institute
Large-scale testing (Phase 3)Looking for participantsNCT03678025What this trial is testingStandard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerWho this might be right forCastration Levels of TestosteroneMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more SWOG Cancer Research Network 1,273
Testing effectiveness (Phase 2)Ended earlyNCT03366103What this trial is testingNavitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmRecurrent Lung Small Cell CarcinomaRecurrent Malignant Solid Neoplasm+6 more National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Active Not RecruitingNCT02115282What this trial is testingExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+4 more National Cancer Institute (NCI) 608
Not applicableNot Yet RecruitingNCT06816979What this trial is testingLumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung CancerWho this might be right forLung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8 Ohio State University Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03695250What this trial is testingBMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver CancerWho this might be right forMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8+5 more Edward Kim 8